Clinical Trial Update: Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCT [Phase 2, Phase 3]

View source ↗

Summary

A randomized trial update on a cytoprotective agent for preventing gastric and duodenal ulcers induced by antiplatelet therapy, with Phase 2 and Phase 3 complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer

Snippet

Sponsor: King Chulalongkorn Memorial Hospital | Conditions: Gastric Ulcer Induced by Anti-platelet Agent, Duodenal Ulcer Induced by Anti-platelet Agent | Phase 2, Phase 3 | Status: COMPLETED